vs
艾伯维（ABBV）与INSPIRE VETERINARY PARTNERS, INC.（IVP）财务数据对比。点击上方公司名可切换其他公司
艾伯维的季度营收约是INSPIRE VETERINARY PARTNERS, INC.的3850.2倍（$16.6B vs $4.3M）。艾伯维净利率更高（10.9% vs -58.5%，领先69.5%）。艾伯维同比增速更快（10.0% vs 6.6%）。艾伯维自由现金流更多（$4.9B vs $-1.3M）。过去两年艾伯维的营收复合增速更高（16.2% vs 2.4%）
艾伯维是一家总部位于美国伊利诺伊州北芝加哥的制药企业，专注于研发、生产覆盖多种疾病领域的治疗药物，致力于为全球各地患者提供安全有效的临床解决方案，在全球医药行业拥有较高的知名度与影响力。
Inspire Veterinary Partners是一家总部位于美国的伴侣动物兽医服务运营商，运营多家宠物诊疗机构，提供预防保健、疾病诊断、外科手术、牙科护理、急诊救治等全流程服务，覆盖美国多州本地社区，服务对象以犬、猫等小型宠物为主。
ABBV vs IVP — 直观对比
营收规模更大
ABBV
是对方的3850.2倍
$4.3M
营收增速更快
ABBV
高出3.4%
6.6%
净利率更高
ABBV
高出69.5%
-58.5%
自由现金流更多
ABBV
多$4.9B
$-1.3M
两年增速更快
ABBV
近两年复合增速
2.4%
损益表 — Q4 2025 vs Q3 2025
| 指标 | | |
|---|---|---|
| 营收 | $16.6B | $4.3M |
| 净利润 | $1.8B | $-2.5M |
| 毛利率 | 72.6% | — |
| 营业利润率 | 27.3% | -45.6% |
| 净利率 | 10.9% | -58.5% |
| 营收同比 | 10.0% | 6.6% |
| 净利润同比 | 8354.5% | 27.6% |
| 每股收益（稀释后） | $1.02 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABBVIVP
| Q4 25 | $16.6B | — | ||
| Q3 25 | $15.8B | $4.3M | ||
| Q2 25 | $15.4B | $4.3M | ||
| Q1 25 | $13.3B | $3.6M | ||
| Q4 24 | $15.1B | $3.3M | ||
| Q3 24 | $14.5B | $4.0M | ||
| Q2 24 | $14.5B | $4.4M | ||
| Q1 24 | $12.3B | $4.8M |
净利润ABBVIVP
| Q4 25 | $1.8B | — | ||
| Q3 25 | $186.0M | $-2.5M | ||
| Q2 25 | $938.0M | $-3.0M | ||
| Q1 25 | $1.3B | $-2.4M | ||
| Q4 24 | $-22.0M | $-4.0M | ||
| Q3 24 | $1.6B | $-3.5M | ||
| Q2 24 | $1.4B | $-3.4M | ||
| Q1 24 | $1.4B | $-3.4M |
毛利率ABBVIVP
| Q4 25 | 72.6% | — | ||
| Q3 25 | 66.4% | — | ||
| Q2 25 | 71.8% | — | ||
| Q1 25 | 70.0% | — | ||
| Q4 24 | 70.9% | — | ||
| Q3 24 | 70.9% | — | ||
| Q2 24 | 70.9% | — | ||
| Q1 24 | 66.7% | — |
营业利润率ABBVIVP
| Q4 25 | 27.3% | — | ||
| Q3 25 | 12.1% | -45.6% | ||
| Q2 25 | 31.7% | -61.1% | ||
| Q1 25 | 28.0% | -55.2% | ||
| Q4 24 | -9.9% | -46.2% | ||
| Q3 24 | 26.5% | -55.2% | ||
| Q2 24 | 27.6% | -54.5% | ||
| Q1 24 | 22.7% | -59.2% |
净利率ABBVIVP
| Q4 25 | 10.9% | — | ||
| Q3 25 | 1.2% | -58.5% | ||
| Q2 25 | 6.1% | -70.8% | ||
| Q1 25 | 9.6% | -66.4% | ||
| Q4 24 | -0.1% | -119.4% | ||
| Q3 24 | 10.8% | -86.2% | ||
| Q2 24 | 9.5% | -77.1% | ||
| Q1 24 | 11.1% | -70.8% |
每股收益（稀释后）ABBVIVP
| Q4 25 | $1.02 | — | ||
| Q3 25 | $0.10 | — | ||
| Q2 25 | $0.52 | — | ||
| Q1 25 | $0.72 | — | ||
| Q4 24 | $-0.03 | — | ||
| Q3 24 | $0.88 | — | ||
| Q2 24 | $0.77 | — | ||
| Q1 24 | $0.77 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.3B | — |
| 总债务越低越好 | $58.9B | $11.8M |
| 股东权益账面价值 | $-3.3B | $4.2M |
| 总资产 | $134.0B | $24.0M |
| 负债/权益比越低杠杆越低 | — | 2.82× |
8季度趋势，按日历期对齐
现金及短期投资ABBVIVP
| Q4 25 | $5.3B | — | ||
| Q3 25 | $5.7B | — | ||
| Q2 25 | $6.5B | — | ||
| Q1 25 | $5.2B | — | ||
| Q4 24 | $5.6B | $523.7K | ||
| Q3 24 | $7.3B | $681.2K | ||
| Q2 24 | $13.2B | $7.7K | ||
| Q1 24 | $18.1B | $69.1K |
总债务ABBVIVP
| Q4 25 | $58.9B | — | ||
| Q3 25 | $63.0B | $11.8M | ||
| Q2 25 | $63.0B | $12.0M | ||
| Q1 25 | $64.5B | $11.5M | ||
| Q4 24 | $60.3B | $12.0M | ||
| Q3 24 | $58.5B | $12.4M | ||
| Q2 24 | $58.0B | $14.6M | ||
| Q1 24 | $63.8B | — |
股东权益ABBVIVP
| Q4 25 | $-3.3B | — | ||
| Q3 25 | $-2.6B | $4.2M | ||
| Q2 25 | $-183.0M | $446.3K | ||
| Q1 25 | $1.4B | $3.0M | ||
| Q4 24 | $3.3B | $1.6M | ||
| Q3 24 | $6.0B | $3.0M | ||
| Q2 24 | $6.8B | $-3.1M | ||
| Q1 24 | $8.0B | $269.9K |
总资产ABBVIVP
| Q4 25 | $134.0B | — | ||
| Q3 25 | $133.9B | $24.0M | ||
| Q2 25 | $137.2B | $20.8M | ||
| Q1 25 | $136.2B | $20.7M | ||
| Q4 24 | $135.2B | $20.2M | ||
| Q3 24 | $143.4B | $22.4M | ||
| Q2 24 | $141.9B | $21.9M | ||
| Q1 24 | $148.9B | $23.4M |
负债/权益比ABBVIVP
| Q4 25 | — | — | ||
| Q3 25 | — | 2.82× | ||
| Q2 25 | — | 26.96× | ||
| Q1 25 | 45.44× | 3.84× | ||
| Q4 24 | 18.15× | 7.67× | ||
| Q3 24 | 9.70× | 4.10× | ||
| Q2 24 | 8.56× | — | ||
| Q1 24 | 7.97× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $5.2B | $-1.3M |
| 自由现金流经营现金流 - 资本支出 | $4.9B | $-1.3M |
| 自由现金流率自由现金流/营收 | 29.4% | -30.7% |
| 资本支出强度资本支出/营收 | 2.0% | 1.0% |
| 现金转化率经营现金流/净利润 | 2.87× | — |
| 过去12个月自由现金流最近4个季度 | $17.8B | $-4.3M |
8季度趋势，按日历期对齐
经营现金流ABBVIVP
| Q4 25 | $5.2B | — | ||
| Q3 25 | $7.0B | $-1.3M | ||
| Q2 25 | $5.2B | $-898.3K | ||
| Q1 25 | $1.6B | $-1.4M | ||
| Q4 24 | $7.0B | $-677.5K | ||
| Q3 24 | $5.4B | $-6.3M | ||
| Q2 24 | $2.3B | $149.7K | ||
| Q1 24 | $4.0B | $-3.2M |
自由现金流ABBVIVP
| Q4 25 | $4.9B | — | ||
| Q3 25 | $6.6B | $-1.3M | ||
| Q2 25 | $4.9B | $-910.9K | ||
| Q1 25 | $1.4B | $-1.4M | ||
| Q4 24 | $6.8B | $-709.4K | ||
| Q3 24 | $5.2B | $-6.3M | ||
| Q2 24 | $2.0B | $126.0K | ||
| Q1 24 | $3.8B | $-3.3M |
自由现金流率ABBVIVP
| Q4 25 | 29.4% | — | ||
| Q3 25 | 42.1% | -30.7% | ||
| Q2 25 | 31.7% | -21.3% | ||
| Q1 25 | 10.5% | -38.3% | ||
| Q4 24 | 44.7% | -21.4% | ||
| Q3 24 | 35.9% | -156.4% | ||
| Q2 24 | 14.0% | 2.9% | ||
| Q1 24 | 31.3% | -68.8% |
资本支出强度ABBVIVP
| Q4 25 | 2.0% | — | ||
| Q3 25 | 2.4% | 1.0% | ||
| Q2 25 | 1.7% | 0.3% | ||
| Q1 25 | 1.8% | 0.6% | ||
| Q4 24 | 1.9% | 1.0% | ||
| Q3 24 | 1.7% | 0.6% | ||
| Q2 24 | 1.7% | 0.5% | ||
| Q1 24 | 1.6% | 3.2% |
现金转化率ABBVIVP
| Q4 25 | 2.87× | — | ||
| Q3 25 | 37.76× | — | ||
| Q2 25 | 5.49× | — | ||
| Q1 25 | 1.27× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.49× | — | ||
| Q2 24 | 1.66× | — | ||
| Q1 24 | 2.95× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ABBV
暂无分部数据
IVP
| Services | $3.1M | 73% |
| Products | $1.2M | 27% |
